AMRN - Rentabilitas operasi Amarin

AMRN (Amarin Corporation) - tandha merek perusahaan

Amarin Corporation plc is implementing environmental standards in the production of cardiovascular drugs, adhering to bioethics and transparency. Business revenues are based on the sale of Vascepa through insurance funds and pharmacies. Changes in the operating margin demonstrate financial stability, while -14.00 shows the level of this metric. Growth prospects are linked to expansion into European markets due to generic pressure in the US.

amarincorp.com (AMRN): Tingkat bathi operasi saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Amarin Corporation plc (AMRN)

- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
Analisis wiwitan perusahaan:AMRN, amarincorp.com
Produk merek Amarin Pharma

For Amarin Corporation plc (AMRN), this indicator serves as a measure of cost management efficiency within the pharmaceutical sector. The ratio of operating profit to revenue, reflected in the operating margin, demonstrates the actual return on every dollar of sales. This metric reveals the business's ability to generate income before accounting for debt obligations. A decline in this figure may signal logistical disruptions or patent disputes. The stability of this value confirms the business model's resilience to geopolitical risks.